Erratum

Article information

J Korean Med Assoc. 2024;67(10):666-666

Publication date (electronic) : 2024 October 10

doi : https://doi.org/10.5124/jkma.2024.67.10.666

Yunkyung Jeon, MD

, In-Joo Kim, MD

Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

J Korean Med Assoc 2022 April; 65(4):241-248

Published online: April 10, 2022

DOI: https://doi.org/10.5124/jkma.2022.65.4.241

This erratum is being published to correct a description on page 241 of the article entitled “Pharmacological treatment of osteoporosis: 2022 update” by Yunkyung Jeon and In-Joo Kim in J Korean Med Assoc 2022;65(4):241-248. DOI: 10.5124/jkma.2022.65.4.241

Before correction

1) 241쪽 저자 소속: 부산대학교병원 내분비대사내과·의생명연구원

Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

After correction

1) 241쪽 저자 소속 추가: 부산대학교 의과대학 부산대학교병원 내분비대사내과·의생명연구원

Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea, Pusan National University College of Medicine, Busan, Korea

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.